Ajemiri Neurotech

Ajemiri Neurotech is an early-stage neurotechnology company based in the UK. The company develops portable, dry-sensor EEG systems enhanced by machine learning to detect biomarkers of Alzheimer’s disease. Ajemiri Neurotech aims to make brain health checks as routine and accessible as blood pressure monitoring, facilitating earlier detection and intervention for dementia. The platform combines consumer-grade hardware with clinical-grade AI to democratize access to cognitive screening in memory clinics, primary care, and large-scale population health initiatives. It utilizes validated EEG biomarkers and proprietary signal-processing pipelines to provide clinicians with a reliable, non-invasive diagnostic aid. Ajemiri Neurotech is currently conducting feasibility research and forming partnerships with academic and clinical institutions.